Violation Tracker Parent Company Summary

Parent Company Name: 
AbbVie
Ownership Structure: 
publicly traded (ticker symbol ABBV)
Headquartered in: 
Illinois
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$3,473,489,112
Number of records: 
48
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
healthcare-related offenses$2,908,816,70311
government-contracting-related offenses$435,190,62923
competition-related offenses$84,850,0006
consumer-protection-related offenses$24,826,9572
financial offenses$15,000,0001
Top 5 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$2,908,700,00010
False Claims Act and related$435,190,62923
price-fixing or anti-competitive practices$43,350,0003
kickbacks and bribery$41,500,0003
consumer protection violation$24,826,9572
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.

For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)
Company Primary Offense Typesort icon Year Agency Penalty Amount
Knoll Pharmaceuticals consumer protection violation 2001 AR-AG $826,957
AbbVie Inc. consumer protection violation 2020 CA-INS $24,000,000
Forest Laboratories, Inc. employment discrimination 2018 private lawsuit-federal $4,000,000
ABBOTT LABS-N CHICAGO PLANT environmental violation 2004 EPA $162,595
ABBOTT LABS - N. CHICAGO PLANT environmental violation 2006 EPA $475,672
ABBOTT LABS - N. CHICAGO PLANT environmental violation 2011 EPA $135,756
ACTAVIS,INC. environmental violation 2015 EPA $30,800
Abbott Laboratories Inc. False Claims Act and related 2010 DOJ_CIVIL $126,500,000
Forest Laboratories and Forest Pharmaceuticals False Claims Act and related 2016 DOJ_CIVIL $38,000,000
Forest Pharmaceuticals Inc. False Claims Act and related 2010 USAO $149,000,000
Allergan Inc. False Claims Act and related 2018 USAO $3,500,000
Abbott Laboratories False Claims Act and related 2009 AL-AG $14,833,333
Abbott Laboratories False Claims Act and related 2013 LA-AG $6,200,000
Abbott Laboratories False Claims Act and related 2008 PA-AG $6,950,000
Abbott Laboratories Inc. False Claims Act and related 2009 OH-AG $1,340,000
Abbott Laboratories Inc. False Claims Act and related 2008 TX-AG $28,000,000
Abbott Laboratories, Inc. False Claims Act and related 2009 IA-AG $357,000
Abbott Laboratories, Inc. False Claims Act and related 2013 ID-AG $1,000,000
Actavis False Claims Act and related 2012 LA-AG $4,000,000
Forest Laboratories False Claims Act and related 2009 AL-AG $14,833,333
Forest Laboratories False Claims Act and related 2013 LA-AG $3,000,000
Forest Laboratories False Claims Act and related 2013 TX-AG $3,000,000
Forest Laboratories LLC False Claims Act and related 2016 MULTI-AG (*) $2,500,000
Forest Laboratories, Inc. False Claims Act and related 2012 ID-AG $790,000
Forest Pharmaceuticals Inc. False Claims Act and related 2010 MULTI-AG (*) $60,000,000
Forest Pharmaceuticals Inc. False Claims Act and related 2012 KY-AG $1,750,000
Warner Chilcott PLC False Claims Act and related 2015 MULTI-AG (*) $10,600,000
Watson/Schein Pharmaceuticals Inc. False Claims Act and related 2011 TX-AG $11,300,000
AbbVie Inc. False Claims Act and related 2019 IL-AG $13,747,929
Forest Laboratories Inc. False Claims Act and related 2019 IL-AG $7,089,034
Allergan Inc. investor protection violation 2017 SEC $15,000,000
Kos Pharmaceuticals kickbacks and bribery 2010 FDA $41,500,000
AbbVie Inc. kickbacks and bribery 2018 MULTI-AG (*) $1,800,000
Kos Pharmaceuticals kickbacks and bribery 2010 MULTI-AG (*) $4,454,432
Actavis Kadian, LLC Medicare Coverage Gap Discount Program violation 2013 CMS $116,703
Abbott Laboratories Inc. off-label or unapproved promotion of medical products 2012 FDA $1,500,000,000
Forest Pharmaceuticals Inc. off-label or unapproved promotion of medical products 2011 FDA $164,000,000
Allergan Inc. off-label or unapproved promotion of medical products 2010 FDA $600,000,000
Warner Chilcott PLC off-label or unapproved promotion of medical products 2015 FDA $125,000,000
Abbott Laboratories off-label or unapproved promotion of medical products 2012 MULTI-AG (*) $339,148,643
Allergan Inc. off-label or unapproved promotion of medical products 2010 MULTI-AG (*) $14,750,000
Allergan Finance LLC off-label or unapproved promotion of medical products 2021 NY-AG $200,000,000
Allergan Ltd. et al. off-label or unapproved promotion of medical products 2022 FL-AG $134,200,000
Allergan Ltd. off-label or unapproved promotion of medical products 2022 RI-AG $7,500,000
Allergan off-label or unapproved promotion of medical products 2022 WV-AG $78,000,000
Abbott Laboratories price-fixing or anti-competitive practices 2005 MULTI-AG $15,350,000
Abbott Laboratories and Fournier Industrie et Sante and Laboratoires Fournier S.A. price-fixing or anti-competitive practices 2010 MULTI-AG $22,500,000
Warner Chilcott Holdings price-fixing or anti-competitive practices 2007 MULTI-AG $5,500,000
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)